Close
Novotech

South Australia Government Looks To Boost Biomanufacturing

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

FDA Advisory Panel to Assess Oversight of Peptide Substances

The U.S. Food and Drug Administration is preparing to...

Smart Packaging: The Strategic Imperative for Pharma’s Future (Beyond Compliance)

Smart packaging reflects key trends in the pharmaceutical industry...

PacBio, Covaris Advance HiFi Sequencing Workflow for FFPE

A new integrated approach to long-read sequencing of archived...
- Advertisement -

Biomanufacturing industry is all set to get the much-needed push by the recent South Australian Government’s announcement when it comes to new initiatives as far as training and development of next generation researchers in this field are concerned.

This will help support the collaborations that the University of Adelaide already has with the sector partners. Apparently, a novel industry-linked initiative has been put in place as a part of the government’s Industry Doctoral Training Center push that brings together the universities of the state with numerous industry partners.

It is well to be noted that biomanufacturing is a kind of manufacturing or biotechnology that makes use of biological systems to commercially produce significant biomolecules and biomaterials for usage in medicine, industrial applications, as well as food and beverage processing. For instance, the University of Adelaide is collaborating with one of the companies that is into the manufacturing of next-generation vaccines. Apparently, the collaboration is going to be on a novel mRNA vaccine development that is not going to require any sort of ultracold storage or transportation, as confirmed by BioProcess Engineering professor from the University of Adelaide, Robert Falconer.

PhD students are going to be a part of the group, which will be working on projects that will be co-designed with the partners of the university and thereby offer peer-to-peer learning as well as mutual support.

They will have the opportunity to enhance their skills, which will in turn set them on a growth trajectory in their respective careers and also provide them with a wide range of opportunities simultaneously with specific doctoral trainings so as to develop contacts and also understand the sectors as well as business requirements. It has been decided that the PhD researchers will begin their training under the new initiative this year itself.

Latest stories

Related stories

FDA Advisory Panel to Assess Oversight of Peptide Substances

The U.S. Food and Drug Administration is preparing to...

Smart Packaging: The Strategic Imperative for Pharma’s Future (Beyond Compliance)

Smart packaging reflects key trends in the pharmaceutical industry...

PacBio, Covaris Advance HiFi Sequencing Workflow for FFPE

A new integrated approach to long-read sequencing of archived...

Innovating Neuropathy Treatment: The Pharmaceutical Pursuit of Enhanced Oxygen Delivery

Strategies that address tissue hypoxia and metabolic dysfunction at...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »